Penapisan Senyawa Antimalaria yang Berasal dari Tumbuhan

  • SYAMSUDIN SYAMSUDIN UNIVERSITAS PANCASILA

Abstract

Efforts to discover and develop new antimalarial drugs have increased dramatically in recent years mainly because of the parasites’ resistance to existing antimalarial drugs. Selection of drug candidates for clinical trials in man and the design of clinical protocols are based upon consideration of data from a battery of preclinical test systems. All compounds are assessed initially in one or more primary models. A compound which is considered active by well established criteria in primary screening test is considered for further evaluation in successively more rigorous clinical test. At the end of each stage of testing, a decision is taken to advance the compound to the next stage or to discontinue it. Primary screening tests should have optimal sensitivity, a high degree of reproducibility, high throughput, should require a minimum quantity of test compound and bear low cost. As there is growing need for newer and more efficacious antimalarial drugs escpecially in tropical countries, more sensitive and economical screening models are needed. This review is an update of various conventional and latest in vitro and in vivo screening methods being used for evaluation of antimalarial compounds.

References

1. Mustofa. Molekul antimalarial alami: potensi dan tantangan pengembangannya sebagai obat baru untuk malaria. MOT. 2003.8(26):8-18.

2. Rieckmann KH, Sax LJ , Cam GH, Mrema JE. Drug susceptibility of Plasmodium falciparum. An in vitro microtechnique. Lancet 1 .1978:22-3.

3. Desjardins RE, Caniield CJ, Haynes DE, Chulay JD. Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique. Antimicrob Agents Chemother. 1979.(16):710-8.

4. Mackler MT, Hinrichs DJ. Measurement of lactate dehydrogenase activity of Plasmodium falciparum as an assessment of parasitemia. Am J Trop Med. 1993.(48):205-10.
5. Trager W, Jensen JB. Human malaria parasites in continuous culture. Science. 1976.(193):673-5.

6. Dennis E, Kyle H, Webster K. In vitro antimalarial drug susceptibility. 2002.

7. Makler MT, Ries JM, Wiliams JA, et al. Parasite lactate dehydrogenase as an assay for Plasmodium falciparum drug sensitivity. Am J Trop Med. 1993. 48(6):739-41.

8. Markell EK, Voge M, John DT. Medical parasitology. 6th ed. Philadeplphia: WB Saunders Company; 1986.

9. Iqbal J, Hira P, Sher A, Al-Eneji A. Diagnosis of imported malaria by Plasmodium lactate dehydrogenase (pLDH) and histidine-rich protein-2 (PtHRP-2)-based immunocapture assays. Am J Trop Med. 2001.64(1):20-3

10. Peters W. Techniques for the study of drug response in experimental malaria, chemotherapy and drug resistance in malaria. New York: Academic; 197O.p.64-136.

11. O’Neill MJ. Bray DH, Boardman P, Phillipson JD, Warhurst DC. Plants as sources of antimalarial drugs, part I: in vitro test method for the evaluation of crude extract from plants. Plant. Med. 1985.(5):384-397.

12. Phillipson JD. Assays for antimalarial and amoebicidal activities. In: Dey PM, Harborne JB. Methods in plants biochemistry. Vol. 6. Assays for bioactivity. London: Academic Press Harcourt Brace Jovanovich Publisher; 1991.p.135-52.

13. Wernsdorfer WH, Payne D. Drug sensitivity test in malaria parasites. In: Wernsdorfer WH and Mc Gregor. Malaria principles and practice on malariology. Vol. II. London: Churchill; 1988.p.1765-92.
Published
2008-09-30
How to Cite
SYAMSUDIN, SYAMSUDIN. Penapisan Senyawa Antimalaria yang Berasal dari Tumbuhan. JURNAL ILMU KEFARMASIAN INDONESIA, [S.l.], v. 6, n. 2, p. 95-99, sep. 2008. ISSN 2614-6495. Available at: <http://jifi.farmasi.univpancasila.ac.id/index.php/jifi/article/view/408>. Date accessed: 20 apr. 2024.
Citation Formats
Issue
Vol 6 No 2 (2008): JIFI
Section
Articles
License

Licencing
All articles in Jurnal Ilmu Kefarmasian Indonesia are an open-access article, distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License which permits unrestricted non-commercial used, distribution and reproduction in any medium.

This licence applies to Author(s) and Public Reader means that the users mays :

  • SHARE:
    copy and redistribute the article in any medium or format
  • ADAPT:
    remix, transform, and build upon the article (eg.: to produce a new research work and, possibly, a new publication)
  • ALIKE:
    If you remix, transform, or build upon the article, you must distribute your contributions under the same license as the original.
  • NO ADDITIONAL RESTRICTIONS:
    You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.

It does however mean that when you use it you must:

  • ATTRIBUTION: You must give appropriate credit to both the Author(s) and the journal, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.

You may not:

  • NONCOMMERCIAL: You may not use the article for commercial purposes.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.